Skip to main content
. 2017 Jun 15;2017:1732571. doi: 10.1155/2017/1732571

Table 2.

Clinicopathological factors associated with at least 5 SBN evaluations at back table and frozen section (step 7 in checklist).

Success in step 7 (n = 82) Failure in step 7 (n = 13) P ∗∗ P
Learning curve 0.734
 First half cases 40 (85.1%) 7 (14.9%)
 Last half cases 42 (87.5%) 6 (12.5%)
Age (years) 1.000
 <60 53 (86.9%) 8 (13.1%)
 ≥60 29 (85.3%) 5 (14.7%)
Gender 0.558
 Male 37 (84.1%) 7 (15.9%)
 Female 45 (88.2%) 6 (11.8%)
BMI (kg/m2) 0.028 0.042
 <23.0 33 (97.1%) 1 (2.9%) Odds ratio = 8.082 Odds ratio = 10.322
 ≥23.0 49 (80.3%) 12 (19.7%) 95% CI = 1.002~65.156 95% CI = 1.082~98.437
Longitudinal tumor locations 0.319
 Lower 1/3 45 (81.8%) 10 (18.2%)
 Middle 1/3 36 (92.3%) 3 (7.7%)
 Upper 1/3 1 (100.0%) 0 (0%)
Circumferential tumor locations 0.059
 Lesser curvature 24 (92.3%) 2 (7.7%)
 Greater curvature 27 (90.0%) 3 (10.0%) 0.881
 Anterior wall 21 (91.3%) 2 (8.7%) 0.812
 Posterior wall 10 (62.5%) 6 (37.5%) 0.056
Number of sentinel basin 0.313
 1 32 (82.1%) 7 (17.9%)
 ≥2 50 (89.3%) 6 (10.7%)
Sentinel basin location 0.666
 Lesser curvature 27 (90.0%) 3 (10.0%)
 Greater curvature 28 (82.4%) 6 (17.6%)
 LC + GC 27 (87.1%) 4 (12.9%)
LN station of sentinel basin 0.593
 N1 group (LN numbers 1~6) 74 (85.1%) 13 (14.9%)
 N2 group (LN numbers 7, 8a, 9, and 11d) 8 (100.0%) 0 (0%)
Endoscopic tumor size (cm) 0.156 0.054
 ≤2 36 (92.3%) 3 (7.7%)
 >2 46 (82.1%) 10 (17.9%)
Histology 0.210 0.105
 Tubular adenocarcinoma 54 (90.0%) 6 (10.0%)
 Signet ring cell carcinoma 26 (78.8%) 7 (21.2%)
pT 0.644
 T1 73 (86.9%) 11 (13.1%)
 T2~4 9 (81.8%) 2 (18.2%)
pN 1.000
 N0 72 (85.7%) 12 (14.3%)
 N1~3 10 (90.9%) 1 (9.1%)

Chi-square test or Fisher's exact test. ∗∗Multivariate analysis, using factors of P < 0.25. BMI: body mass index; CI: confidence interval; LN: lymph node.